Search
Coagulation factor VIIa Recombinant Human
Recombinant human coagulation Factor VIIa (rFVIIa), intended for promoting hemostasis by activating the extrinsic pathway of the coagulation cascade. NovoSeven is a vitamin K-dependent glycoprotein consisting of 406 amino acid residues. Cloned and expressed in hamster kidney cells, the protein is catalytically activ...
Antihemophilic Factor Human Recombinant Action Pathway
smpdb.ca/view/SMP0126774Drug actionAntihemophilic factor, human recombinant is administered intravenously and acts to correct coagulation defects, by activating coagulation factor X and IX. … Antihemophilic factor, human recombinant of the coagulation Factor VIII, also known as Advate, Adynovate, Helixate, Kogenate, Kovaltry, Novoeight, Recombinate, to treat hemophilia A, von Willebrand disease
Enzymes: Coagulation factor VIIa, Coagulation factor VIIIAntihemophilic Factor Human Action Pathway
smpdb.ca/view/SMP0126841Drug actionAdministered intravenously the antihemophilic factor human replaces the abnormal coagulation factor VIII, acting as a cofactor to activate coagulation factor IX and X. … It is a non-recombinant concentrate of the endogenous coagulation factor VIII, produced by reducing von Willebrand Factor antigen and purified by affinity chromatography.
Enzymes: Coagulation factor VIIa, Coagulation factor VIIIAlteplase Action Pathway
smpdb.ca/view/SMP0126634Drug actionAlteplase is a recombinant plasminogen activator present in human tissue, also known as Activase, Cathflo and Cathflo Activase used to treat emergencies such as myocardial infarction, ischemic stroke and
Enzymes: Coagulation factor VIIa, Coagulation factor VIIISevere Bleeding
go.drugbank.com/conditions/DBCOND0060436Moroctocog Alfa Action Pathway
smpdb.ca/view/SMP0126849Drug actionMoroctocog alfa also known as Refacto AF and Xyntha, is a B-domain deleted recombinant factor VIII similar to the endogenous coagulation factor VIII. … It acts by replacing coagulation factor VIII which is deficient in those with hemophilia, this allows coagulation factor IX and X to be activated and facilitate the clotting cascade.
Enzymes: Coagulation factor VIIa, Coagulation factor VIIIEmicizumab Action Pathway
smpdb.ca/view/SMP0126843Drug actionEmicizumab also known as Hemlibra, is a humanized recombinant monoclonal antibody that mimics coagulation factor VIII and can bind to activated coagulation factor IX and X. … Emicizumab performs the function of coagulation factor VIII, with the ability to also bind to both coagulation factor IX and X.
Enzymes: Coagulation factor VIIa, Coagulation factor VIIIReteplase Action Pathway (new)
smpdb.ca/view/SMP0126637Drug actionReteplase is a plasminogen activator that is created as a purified form of human tissue, also known as Retavase that is used in emergencies such as myocardial infarction, ischemic stroke and pulmonary
Enzymes: Coagulation factor VIIa, Coagulation factor VIIIAnistreplase Action Pathway (new)
smpdb.ca/view/SMP0126638Drug actionAnistreplase is a plasminogen activator created from recombinant human tissue, used in emergencies such as myocardial infarction and pulmonary emboli.
Enzymes: Coagulation factor VIIa, Coagulation factor VIIITenecteplase Action Pathway (new)
smpdb.ca/view/SMP0126640Drug actionTenecteplase is a plasminogen activator, a modified form of recombinant human tissue, also known as Metalyse and Tnkase, used in emergencies such as myocardial infarction and pulmonary emboli.
Enzymes: Coagulation factor VIIa, Coagulation factor VIII